P23 Predicted risk of end-stage liver disease utilizing the UK-PBC risk score with continued standard of care and subsequent addition of OCA for 60 months in patients with PBC

Abstract

The UK-PBC Study group validated a long-term prognostic model of primary biliary cholangitis (PBC) that identified independent predictors of end-stage liver disease (ESLD). POISE was a randomized, double-blind (DB), placebo-controlled...